HilleVax, Inc. (NASDAQ:HLVX – Get Rating) shares fell 8.7% during trading on Wednesday . The company traded as low as $14.08 and last traded at $14.38. Approximately 46,721 shares traded hands during mid-day trading, an increase of 17% from the average session volume of 39,765 shares. The stock had previously closed at $15.75. HilleVax Stock […]
HilleVax, Inc. (NASDAQ:HLVX – Get Rating)’s share price traded down 8.7% on Wednesday . The stock traded as low as $14.08 and last traded at $14.38. 46,721 shares were traded during trading, an increase of 17% from the average session volume of 39,765 shares. The stock had previously closed at $15.75. HilleVax Stock Performance The […]
HilleVax (NASDAQ:HLVX – Get Rating) is one of 282 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We will compare HilleVax to related companies based on the strength of its risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation. Earnings & Valuation This table compares […]
HilleVax (NASDAQ:HLVX – Get Rating) is one of 282 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We will compare HilleVax to similar companies based on the strength of its dividends, institutional ownership, profitability, earnings, risk, valuation and analyst recommendations. Institutional & Insider Ownership 99.1% of […]
HilleVax, Inc. (NASDAQ:HLVX – Get Rating) – SVB Leerink increased their Q1 2023 earnings per share (EPS) estimates for shares of HilleVax in a report issued on Tuesday, March 21st. SVB Leerink analyst D. Risinger now expects that the company will post earnings of ($0.81) per share for the quarter, up from their previous estimate […]